Back to VRDN
Bellevue Group AG VRDN Position History
Viridian Therapeutics, Inc. • Healthcare
Quarters held
8
Latest value
$146.3M
Q3 2026
Peak value
$146.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $87K |
| Q4 2025 | $135.6M |
| Q1 2026 | $169K |
| Q1 2026 | $131.4M |
| Q2 2026 | $264K |
| Q2 2026 | $123.4M |
| Q3 2026 | $80K |
| Q3 2026 | $146.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $146.3M | 7.11M | — | — |
| Q3 2026 | $80K | 3.9K | — | — |
| Q2 2026 | $123.4M | 6.72M | — | — |
| Q2 2026 | $264K | 14.4K | — | — |
| Q1 2026 | $131.4M | 6.72M | — | — |
| Q1 2026 | $169K | 8.6K | — | — |
| Q4 2025 | $135.6M | 4.36M | — | — |
| Q4 2025 | $87K | 2.8K | — | — |